This month's top news stories.
Rhesus (Rh) immunoglobulin should be given only after 12 weeks gestation for spontaneous abortion, or for medication or uterine aspiration abortion, according to a new consensus statement from the Society of Family Planning (SFP).
In a recent study, immigrant women were less likely to receive access to timely prenatal care than women born in the United States.
Pfizer announced that its bivalent respiratory syncytial virus vaccine—when given to women during pregnancy—has shown effective in protecting infants from reducing severe symptoms during their first 6 months of birth.
Declining volume and revenue with increasing expenses mean many systems are ending the year in the red.
Breaking down barriers through patient selection, new devices, and the latest techniques.
In an exclusive interview, Nash Moawad, MD, MS, FACOG, FACS, discussed the recent implementation of the Essentials of Minimally Invasive Gynecologic Surgery (EMIGS) training program, which helps physicians provide the best care and ensure optimal safety for their patients.
Revisions to 2016 document focus on provider flexibility and unique circumstances of every prescribing decision.
November is Diabetes Awareness Month.
November 08, 2022
At the 2022 AAP National Conference & Exhibition, a professor from the Baylor College of Medicine discusses how to develop an approach to investigate menstrual disturbances for adolescent patients and understand treatment options.
Houston, Texas, was buzzing with the latest updates in women’s health at the 25th Annual Nurse Practitioners in Women’s Health Premier Women’s Healthcare Conference held from September 29 to October 2, 2022.
A new NIH study found women who used chemical hair straightening products to be at a higher risk for uterine cancer than women who didn’t use these products.
The Food and Drug Administration (FDA) has approved Medicine360’s supplemental new drug application to extend the use of its levongestrel-releasing intrauterine system 52mg (LILETTA) to prevent pregnancy for up to 8 years.
‘Charming Kitten’ believed to be a front for Islamic Revolutionary Guard Corps, according to HHS’ cybersecurity agency.
Daré Bioscience announced yesterday that it has received a grant from the Bill & Melinda Gates Foundation of $584,986 to support its efforts related to the development of a vaginal thermosetting gel formulation for the delivery of live biotherapeutics that can be reconstituted at the point of care.
Telehealth store doesn’t accept insurance yet, but Amazon Pharmacy will deliver prescriptions.
This is the first FDA-approved ADC for platinum-resistant disease, according to ImmunoGen.
Cleveland Clinic begins charging for doctors’ time spent responding to some electronic messages.